These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 15740411)

  • 1. The Global HIV/AIDS Vaccine Enterprise: scientific strategic plan.
    Global HIV/AIDS Vaccine Enterprise
    PLoS Med; 2005 Feb; 2(2):e25. PubMed ID: 15740411
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The global HIV vaccine enterprise.
    Esparza J
    Int Microbiol; 2005 Jun; 8(2):93-101. PubMed ID: 16052457
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The 2010 scientific strategic plan of the Global HIV Vaccine Enterprise.
    Council of the Global HIV Vaccine Enterprise
    Nat Med; 2010 Sep; 16(9):981-9. PubMed ID: 20823883
    [No Abstract]   [Full Text] [Related]  

  • 4. The future of HIV vaccine research and the role of the Global HIV Vaccine Enterprise.
    Voronin Y; Manrique A; Bernstein A
    Curr Opin HIV AIDS; 2010 Sep; 5(5):414-20. PubMed ID: 20978383
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expanding research capacity and accelerating AIDS vaccine development in Asia.
    Excler JL; Pitisuttithum P; Rerks-Ngarm S; Shao Y; Zhang L; Tamashiro H; Osmanov S;
    Southeast Asian J Trop Med Public Health; 2008 Jul; 39(4):766-84. PubMed ID: 19058617
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Defining the objectives of the AIDS vaccine for Asia network: report of the WHO-UNAIDS/Global HIV vaccine enterprise regional consultation on expanding AIDS vaccine research and development capacity in Asia.
    Rerks-Ngarm S; Pitisuttithum P; Ganguly N; Zhang L; Tamashiro H; Cooper DA; Vun MC; Bela B; Ditangco R; Van Kinh N; Bernstein A; Osmanov S; Mathieson B; Kent SJ; Shao Y
    Curr Opin HIV AIDS; 2010 Sep; 5(5):435-52. PubMed ID: 20978386
    [No Abstract]   [Full Text] [Related]  

  • 7. AIDS vaccine for Asia Network (AVAN): expanding the regional role in developing HIV vaccines.
    Kent SJ; Cooper DA; Chhi Vun M; Shao Y; Zhang L; Ganguly N; Bela B; Tamashiro H; Ditangco R; Rerks-Ngarm S; Pitisuttithum P; Van Kinh N; Bernstein A; Osmanov S;
    PLoS Med; 2010 Sep; 7(9):e1000331. PubMed ID: 20877474
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The enterprise changes course.
    McEnery R
    IAVI Rep; 2011; 15(5):9-13. PubMed ID: 22121546
    [No Abstract]   [Full Text] [Related]  

  • 9. A transformed global enterprise for an HIV vaccine.
    Tatoud R; Snow W; Esparza J
    J Int AIDS Soc; 2021 Nov; 24 Suppl 7(Suppl 7):e25822. PubMed ID: 34806318
    [No Abstract]   [Full Text] [Related]  

  • 10. Grappling with global concerns in the search for an HIV vaccine.
    Grady C
    J Assoc Nurses AIDS Care; 1999; 10(1):17-20. PubMed ID: 9934666
    [TBL] [Abstract][Full Text] [Related]  

  • 11. G-8 endorses new global HIV vaccine enterprise.
    Bull World Health Organ; 2004 Jul; 82(7):557. PubMed ID: 15500292
    [No Abstract]   [Full Text] [Related]  

  • 12. An HIV/AIDS vaccine: where do we go from here?
    Bernstein A
    Trends Microbiol; 2008 Dec; 16(12):553-4. PubMed ID: 18964019
    [No Abstract]   [Full Text] [Related]  

  • 13. Partnership for HIV vaccine research in Africa.
    Sanders E
    Ethiop Med J; 2003 Jun; 41 Suppl 1():5-7. PubMed ID: 15227875
    [No Abstract]   [Full Text] [Related]  

  • 14. Canada will have a national HIV vaccine plan.
    Garmaise D
    Can HIV AIDS Policy Law Rev; 2002 Dec; 7(2-3):29. PubMed ID: 14719491
    [TBL] [Abstract][Full Text] [Related]  

  • 15. G8 support for vaccine initiative draws mixed reactions. HIV-vaccine enterprise promises to mobilise billions of dollars for research and make projects more global.
    Walgate R
    Lancet; 2004 Jun; 363(9426):2055. PubMed ID: 15209077
    [No Abstract]   [Full Text] [Related]  

  • 16. The challenges of an HIV vaccine enterprise.
    Wolf H
    Science; 2004 Feb; 303(5662):1294-7; author reply 1294-7. PubMed ID: 14991961
    [No Abstract]   [Full Text] [Related]  

  • 17. Accelerating the development of an AIDS vaccine: the AIDS vaccine for Asia Network (Avan).
    Pitisuttithum P; Rerks-Ngarm S; Chiu J; Kim J; Benenson M; Kent SJ; Tamashiro H; Manrique A; Bernstein A; Goyal R; Ditangco RA; Cooper DA; Osmanov S; Mathieson B; Sandstrom E; Esparza J; Hoff R; Shao Y;
    Southeast Asian J Trop Med Public Health; 2011 Sep; 42(5):1130-46. PubMed ID: 22299439
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The end of HIV: how do we get there?
    Pinto AN; Cooper D
    Med J Aust; 2014 Jul; 201(2):77-8. PubMed ID: 25045975
    [No Abstract]   [Full Text] [Related]  

  • 19. Controlling and ultimately ending the HIV/AIDS pandemic: a feasible goal.
    Folkers GK; Fauci AS
    JAMA; 2010 Jul; 304(3):350-1. PubMed ID: 20639573
    [No Abstract]   [Full Text] [Related]  

  • 20. U.S. Military HIV Research Program: successfully integrating HIV vaccine research with prevention, care, and treatment.
    Reilly L
    Mil Med; 2010 Jul; 175(7 Suppl):42-4. PubMed ID: 23634478
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.